(DRUG) Bright Minds - Performance 2577.7% in 12m
DRUG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
4.13%
#34 in Peer-Group
Rel. Strength
99.96%
#4 in Stock-Universe
Total Return 12m
2577.67%
#2 in Peer-Group
Total Return 5y
2.15%
#36 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 55.77 USD |
| 52 Week Low | 0.96 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 30.80 |
| Buy/Sell Signal +-5 | -1.40 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: DRUG (2577.7%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: DRUG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DRUG
| Total Return (including Dividends) | DRUG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.77% | 7.76% | 1.11% |
| 3 Months | -23.96% | -5.31% | 5.58% |
| 12 Months | 2577.67% | -7.58% | 10.51% |
| 5 Years | 2.15% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | DRUG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -50.1% | 84.2% | 69.9% |
| 3 Months | -77.8% | -2.8% | 69.3% |
| 12 Months | 46.4% | -77.8% | 43.2% |
| 5 Years | -21.9% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #187 | -20.91% | -15.70% |
| 3 Month | #153 | -19.70% | -27.98% |
| 12 Month | #1 | 2797.25% | 2323.02% |
| 5 Years | #28 | 79.46% | -36.54% |
FAQs
Does Bright Minds (DRUG) outperform the market?
Yes,
over the last 12 months DRUG made 2577.67%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months DRUG made -23.96%, while XBI made -5.31%.
Performance Comparison DRUG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
DRUG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.6% | -15.9% | -28% | 2567% |
| US NASDAQ 100 | QQQ | -0.4% | -16.3% | -27.2% | 2568% |
| German DAX 40 | DAX | 1.6% | -14% | -44.3% | 2548% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | -13.8% | -29.8% | 2566% |
| Hongkong Hang Seng | HSI | -1.1% | -19.8% | -47% | 2550% |
| India NIFTY 50 | INDA | 1.1% | -13.4% | -26.9% | 2579% |
| Brasil Bovespa | EWZ | -3% | -15.2% | -48.2% | 2569% |
DRUG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -16.2% | -30.8% | 2555% |
| Consumer Discretionary | XLY | -0.1% | -13% | -18.1% | 2560% |
| Consumer Staples | XLP | -0.3% | -14.6% | -29.4% | 2571% |
| Energy | XLE | -6.5% | -17.7% | -31.6% | 2575% |
| Financial | XLF | 1% | -12.2% | -30.8% | 2554% |
| Health Care | XLV | -2.6% | -19.1% | -27.5% | 2583% |
| Industrial | XLI | 0.4% | -15.1% | -33.5% | 2559% |
| Materials | XLB | 0% | -16.2% | -28.7% | 2578% |
| Real Estate | XLRE | -1.2% | -15.7% | -29% | 2565% |
| Technology | XLK | -0.9% | -16.8% | -28.4% | 2573% |
| Utilities | XLU | -2% | -15.3% | -36.3% | 2556% |
| Aerospace & Defense | XAR | 0.4% | -20.5% | -44.9% | 2535% |
| Biotech | XBI | -0.3% | -22.5% | -17.2% | 2585% |
| Homebuilder | XHB | 1% | -9.8% | -12.5% | 2587% |
| Retail | XRT | 3.3% | -14.6% | -20% | 2577% |
DRUG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -12.4% | -33.5% | -37.8% | 2575% |
| Natural Gas | UNG | 0.1% | -12.2% | -46.2% | 2592% |
| Gold | GLD | -4.2% | -21% | -58.1% | 2530% |
| Silver | SLV | 0.2% | -26.1% | -47.6% | 2555% |
| Copper | CPER | 1.9% | -16.5% | -42.8% | 2569% |
DRUG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.1% | -15.5% | -26.5% | 2582% |
| iShares High Yield Corp. Bond | HYG | -1.1% | -15.3% | -31.6% | 2569% |